Nov
04

Amylin watches its R&D costs continue to rise. : An article from: San Diego Business Journal

By Pharma Tech


Product Description
This digital document is an article from San Diego Business Journal, published by CBJ, L.P. on November 4, 2002. The length of the article is 438 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Amylin watches its R&D costs continue to rise. (Biotech).(Amylin Pharmaceuticals research and development spending)
Author: Marion Webb
Publication: San Diego Business Journal (Magazine/Journal)
Date: November 4, 2002
Publisher: CBJ, L.P.
Volume: 23 Issue: 44 Page: 13(1)

Distributed by Thomson Gale
Amylin watches its R&D costs continue to rise. : An article from: San Diego Business Journal

Share and Enjoy:
  • Print this article!
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks
Categories : Trials

Leave a Comment

CommentLuv Enabled

This site uses KeywordLuv. Enter YourName@YourKeywords in the Name field to take advantage.